Researchers have made progress in developing liquid biopsies for brain tumors by detecting tumor DNA in the cerebrospinal fluid of glioma patients.
Researchers have uncovered the role of cellular prion protein (PrPC) in Neurofibromatosis Type 2 (NF2) related tumors, offering hope to neuro-tumor patients.
New study demonstrates how the enzyme, ACSS2, contributes to brain tumor growth in environments scarce of oxygen and nutrients.
Karmakar & Reilly review what is known about the role of NF1 mutation in immune cell function & the role of immune cells in promoting tumorigenesis in NF1.
New research has elucidated a pathway in diffuse intrinsic pontine glioma with promise for therapeutic targeting.
Researchers have developed novel mini ‘artificial brains’ to model glioma tumor growth: the organoids could soon be used to develop personalized treatment strategies against brain cancers.
A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma
This summary guideline outlines methods for starting patients on TTFields, for monitoring patient response to therapy and provides a framework for evaluating when therapy should be re-planned.
We speak to David Vigerust, author of ‘Neuroinflammation: a precursor and promoter of oncogenesis’, about his research and the role of trauma in oncogenesis.
A key protein has been identified that could be targeted in new treatments against glioblastoma, one of the deadliest forms of brain cancer.
This review explores the current status of diagnosis, management and treatment of CNS germ cell tumors as well future directions for therapies.